Hirakata, Japan

Katsumi Yamanaga

This inventor holds 1 USPTO granted patent. Top assignee: The Green Cross Corporation. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsumi Yamanaga. Retrieved from https://idiyas.com/inventor/katsumi-yamanaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsumi Yamanaga: Innovator in Pharmaceutical Applications

Introduction

Katsumi Yamanaga is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work with dihydropyridine derivatives. His expertise and dedication to research have led to the development of valuable patents that enhance medical treatments.

Latest Patents

Katsumi Yamanaga holds a patent for the pharmaceutical use of dihydropyridine derivative. This patent represents a crucial advancement in the pharmaceutical industry, showcasing his ability to create effective solutions for health-related challenges. He has 1 patent to his name, reflecting his commitment to innovation.

Career Highlights

Yamanaga is currently employed at The Green Cross Corporation, a company known for its focus on healthcare and pharmaceutical products. His role at the company allows him to collaborate with other talented professionals in the field, furthering the impact of his work.

Collaborations

Throughout his career, Katsumi has worked alongside esteemed colleagues such as Masahide Nakajima and Norifumi Nakamura. These collaborations have enriched his research and contributed to the success of various projects.

Conclusion

Katsumi Yamanaga is a distinguished inventor whose work in pharmaceuticals has made a significant impact. His innovative approach and dedication to research continue to drive advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…